Physician profile
Brandon Ito
NPI 1962022129
$2,513.62
in general payments reported to CMS, 2019-2025
9 companies · $821 in 2025
The $821 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $273 · 2023: $642 · 2024: $778 · 2025: $821.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,240.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,820.59 | 2022-2025 | |
| Pfizer INC. | $142.40 | 2023-2025 | |
| Csl Behring | $124.99 | 2025 | Kcentra |
| Astrazeneca Pharmaceuticals LP | $121.86 | 2024 | Andexxa |
| Neurocrine Biosciences, INC. | $121.30 | 2024 | Ingrezza |
| Dilon Technologies, INC. | $112.31 | 2025 | Hemoblast Bellows |
| Biohaven Pharmaceutical Holding Company LTD. | $44.60 | 2022 | |
| Impel Pharmaceuticals INC. | $22.64 | 2023 | Trudhesa |
| Impel Pharmaceuticals LLC | $2.93 | 2024 | Trudhesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Ito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.